Umicore
Short position disclosed on July 16, 2026.
0.70% of the capital sold short
1 disclosing funds
312 disclosures on record
BE0974320526 ISIN code
Funds holding Umicore Titelia
Evolution of the disclosed total
0%0.2%0.4%0.6%0.8%
Oct 2025Jan 2026Apr 2026Jul 2026
June 19, 2013 today
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| Capital Fund Management | 0.70% | new | July 16, 2026 |
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| November 29, 2013 | Marshall Wace LLP | 0.62% | December 4, 2013 |
| November 26, 2013 | Marshall Wace LLP | 0.53% | November 29, 2013 |
| October 24, 2013 | Marshall Wace LLP | 0.57% | October 28, 2013 |
| October 22, 2013 | Marshall Wace LLP | 0.69% | October 24, 2013 |
| October 2, 2013 | Marshall Wace LLP | 0.72% | October 22, 2013 |
| September 24, 2013 | Marshall Wace LLP | 0.61% | October 2, 2013 |
| September 19, 2013 | Marshall Wace LLP | 0.51% | September 24, 2013 |
| August 2, 2013 | Marshall Wace LLP | 0.59% | August 6, 2013 |
| July 30, 2013 | Marshall Wace LLP | 0.61% | August 2, 2013 |
| July 25, 2013 | Marshall Wace LLP | 0.51% | July 30, 2013 |
| June 27, 2013 | Millennium Capital Partners LLP | 0.50% | June 28, 2013 |
| June 19, 2013 | Millennium Capital Partners LLP | 0.50% | June 20, 2013 |
Other companies sold short in Belgium
- Solvay 2.07% of the capital sold short
- Biocartis 1.21% of the capital sold short
- Barco 1.02% of the capital sold short
- CP Invest 0.98% of the capital sold short
- D'Ieteren Group 0.89% of the capital sold short
- Syensqo 0.89% of the capital sold short
- EVS 0.80% of the capital sold short
- Azelis 0.71% of the capital sold short
- Lotus Bakeries 0.69% of the capital sold short
- Sequana Medical 0.69% of the capital sold short
- WDP 0.51% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Umicore, source FSMA, data as at July 16, 2026, https://www.quivad.com/action/umicore?page=7